Ulcerative Colitis
Ulcerative colitis is a chronic inflammatory bowel disease that causes inflammation and ulcers in the lining of the colon, leading to symptoms like abdominal pain, diarrhea, and rectal bleeding.
Ulcerative Colitis and Crohn’s Disease: Long-term Study of Zasocitinib
We are investigating the long-term safety and effectiveness of oral zasocitinib in adults with moderately to severely active ulcerative colitis and Crohn’s disease. This study is for those who have responded to treatment in previous trials.
>2 years6-10 visitsEfficacy phase (II)Post-Trial Drug AccessNo PlaceboCost ReimbursementInvestigational MedicinesOralGastroenterologyInternal Medicine
What diseases are being studied?
Health conditions and diseases that the clinical trial is designed to study and treat.
Crohn's Disease
Crohn's disease is a type of inflammatory bowel disease that can affect any part of the gastrointestinal tract, causing symptoms such as abdominal pain, severe diarrhea, fatigue, and weight loss.
Who can participate in the clinical trial?
These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..
- Are you between 18 and 75 years old?
- Are you pregnant, nursing, or planning to become pregnant during the trial?
- Do you have any type of cancer or precancerous condition diagnosed by a doctor?
- Are you currently taking any oral corticosteroids like Prednisone or Hydrocortisone?
- Do you have severe kidney problems or liver problems?
What experimental substances are being tested?
Experimental substances that are being investigated in this clinical trial. These are not yet approved for general use.
Zasocitinib
Where is the clinical trial being conducted?
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Loading map...
UZ Leuven
Gastroenterology and hepatology
Heverlee, Belgium
Hopital Erasme
Gastroenterology
Negenmanneke, Belgium
CHU Saint Pierre
Gastroenterology
Saint-Gilles, Belgium
Sponsor: Takeda Development Center Americas Inc.
Last updated: Nov 27, 2025
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.